[
  {
    "ts": "2025-07-04T08:19:00+00:00",
    "headline": "North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE",
    "summary": "The North America Beta Glucan Market, valued at USD 204.03 million in 2024, is poised to grow to USD 373.85 million by 2033, with a CAGR of 6.96% from 2025 to 2033. This growth is driven by rising consumer demand for immune-boosting and functional food ingredients and increased awareness of beta glucan's health benefits. Beta glucan—a soluble fiber found in grains, fungi, and yeast—offers cholesterol-reducing and immune-modulating properties, gaining traction in functional foods, nutraceuticals,",
    "url": "https://finance.yahoo.com/news/north-america-beta-glucan-market-081900496.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "57ed1d03-307b-3667-a67c-4631a412a0c1",
      "content": {
        "id": "57ed1d03-307b-3667-a67c-4631a412a0c1",
        "contentType": "STORY",
        "title": "North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE",
        "description": "",
        "summary": "The North America Beta Glucan Market, valued at USD 204.03 million in 2024, is poised to grow to USD 373.85 million by 2033, with a CAGR of 6.96% from 2025 to 2033. This growth is driven by rising consumer demand for immune-boosting and functional food ingredients and increased awareness of beta glucan's health benefits. Beta glucan—a soluble fiber found in grains, fungi, and yeast—offers cholesterol-reducing and immune-modulating properties, gaining traction in functional foods, nutraceuticals,",
        "pubDate": "2025-07-04T08:19:00Z",
        "displayTime": "2025-07-04T08:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/8367ac568d19e14f8c4643521a9b56d9",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "North American Beta-Glucan Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.ZlgZ8RaaWa0Kbwuns6ugw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8367ac568d19e14f8c4643521a9b56d9.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/c6V9M.ZypN57ajHjCwY7VA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8367ac568d19e14f8c4643521a9b56d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/north-america-beta-glucan-market-081900496.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/north-america-beta-glucan-market-081900496.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PHIA.AS"
            },
            {
              "symbol": "EDAP"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "6501.T"
            },
            {
              "symbol": "ALTHE.PA"
            },
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-04T07:23:01+00:00",
    "headline": "Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy",
    "summary": "Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy. On June 25, Stryker Corporation (NYSE:SYK) announced that its Incompass Total Ankle System, intended for patients with severe rheumatoid, post-traumatic, or degenerative arthritis-related ankle joint damage, received FDA 510(k) clearance. The Incompass system integrates Adaptis Boney Ingrowth Technology and revised instrumentation to facilitate long-term […]",
    "url": "https://finance.yahoo.com/news/stryker-incompass-system-secures-fda-072301025.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "eed6a52e-cd54-300b-810e-853d692f35d4",
      "content": {
        "id": "eed6a52e-cd54-300b-810e-853d692f35d4",
        "contentType": "STORY",
        "title": "Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy",
        "description": "",
        "summary": "Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy. On June 25, Stryker Corporation (NYSE:SYK) announced that its Incompass Total Ankle System, intended for patients with severe rheumatoid, post-traumatic, or degenerative arthritis-related ankle joint damage, received FDA 510(k) clearance. The Incompass system integrates Adaptis Boney Ingrowth Technology and revised instrumentation to facilitate long-term […]",
        "pubDate": "2025-07-04T07:23:01Z",
        "displayTime": "2025-07-04T07:23:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ab5398c83c831f273f24ed596fdfd9ea",
          "originalWidth": 430,
          "originalHeight": 250,
          "caption": "Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5sBKzHSWVTQYOO.yV.Zbow--~B/aD0yNTA7dz00MzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ab5398c83c831f273f24ed596fdfd9ea.cf.webp",
              "width": 430,
              "height": 250,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RdmqOYxEw9NvOla454IIIQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ab5398c83c831f273f24ed596fdfd9ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stryker-incompass-system-secures-fda-072301025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stryker-incompass-system-secures-fda-072301025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]